monoethylglycinexylidide has been researched along with Biliary Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boni, M; Caputo, M; Frameglia, M; Guglielmi, A; Schinella, M; Veraldi, GF | 1 |
| Actis, GC; Arrigoni, A; Benedetti, P; Cappello, N; Gindro, T; Martinasso, G; Perardi, S; Rizzetto, M; Rosina, F; Verme, G | 1 |
1 trial(s) available for monoethylglycinexylidide and Biliary Cirrhosis
| Article | Year |
|---|---|
Monoethyl glycine xylidide (MEGX) test evaluation in primary biliary cirrhosis: comparison with Mayo score.
Topics: Adult; Aged; Evaluation Studies as Topic; Female; Humans; Lidocaine; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Prognosis; Prospective Studies; Survival Rate | 1997 |
1 other study(ies) available for monoethylglycinexylidide and Biliary Cirrhosis
| Article | Year |
|---|---|
Evaluation of the liver function of cirrhotic patients based on the formation of monoethylglycine xylidide (MEGX) from lidocaine.
Topics: Adult; Aged; Evaluation Studies as Topic; Female; Fluorescence Polarization Immunoassay; Humans; Lidocaine; Liver; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Portasystemic Shunt, Surgical; Sclerotherapy | 1993 |